US 12076405
Heterocyclic degronimers for target protein degradation
granted A61KA61K31/4035A61K31/438
Quick answer
US patent 12076405 (Heterocyclic degronimers for target protein degradation) held by C4 THERAPEUTICS, INC. expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- C4 THERAPEUTICS, INC.
- Grant date
- Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/4035, A61K31/438, A61K31/439, A61K31/454